Related Experiment Video
Updated: Jun 9, 2026
09:48
Dorsal Root Ganglion Injection and Dorsal Root Crush Injury as a Model for Sensory Axon Regeneration
Published on: May 3, 2017
17.9K
AAV-mediated interneuron-specific gene replacement for Dravet syndrome
Biorxiv : the Preprint Server for Biology
|January 3, 2024
Summary
Gene therapy targeting interneurons with AAV-delivered SCN1A shows promise for Dravet syndrome (DS). This approach successfully restored functional sodium channels, significantly reducing seizures and mortality in DS mouse models.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Dravet syndrome (DS) is a severe neurodevelopmental disorder characterized by drug-resistant epilepsy and cognitive deficits.
- Loss-of-function mutations in the SCN1A gene, encoding the Nav1.1 sodium channel, are the primary cause of DS, leading to impaired inhibitory neuron function.
Conclusions:
- Interneuron-specific AAV-mediated SCN1A gene replacement is a viable therapeutic strategy for Dravet syndrome.
- This targeted approach offers significant rescue potential in preclinical models, suggesting a promising avenue for human clinical trials.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...